AUPH AURINIA PHARMACEUTICALS INC Earnings Reports 8-K Filing 2025 - Financial Statements On May 12, 2025, Aurinia Pharmaceuticals Inc. announced its financial results for the quarter ended March 31, 2025, reflecting its operational status. The filing is a routine quarterly earnings report and is considered significant.Get access to all SEC 8-K filings of the AURINIA PHARMACEUTICALS INC